<h1>Assess franchise and contract manufacturing risks in Ayurvedic and veterinary PCD businesses: exclusivity, compliance, procurement, liability</h1> A private press release promotes growth in Ayurvedic and veterinary PCD franchising and third-party manufacturing, highlighting low capital entry, exclusive territorial distribution rights, franchisor support, and scalability. It notes government healthcare funding and digital health rollouts and cites public procurement mechanisms (tenders and subsidized outlets) that create B2B market opportunities. Legally salient issues include franchise agreement terms (exclusivity, territorial scope, IP/use of trademarks), regulatory compliance for pharmaceuticals and veterinary products, quality and certification obligations for contract manufacturers, and procurement/bid requirements for government schemes. Parties should assess contract risk allocation, product liability, regulatory approvals, and tender eligibility before entering agreements.